Compound Summary
Compound Information
cannabidiol
Compound Name: | cannabidiol |
Compound CID: | 644019 |
Synonyms: | cannabidiol 13956-29-1 (-)-Cannabidiol (-)-trans-Cannabidiol Epidiolex More... |
Iupac Name: | 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol |
InChI: | InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1 |
InChIKey: | QHMBSVQNZZTUGM-ZWKOTPCHSA-N |
Canonical Smiles: | CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O |
Isomeric Smiles: | CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O |
Molecular Weight: | 314.5 |
Molecular Formula: | C21H30O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
cannabidiol
Molecular Weight: | 314.5 |
Molecular Formula: | C21H30O2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 23 |
Complexity: | 414 |
Synonyms
cannabidiol
| cannabidiol | cannabidiol |
|---|---|
cannabidiol |
13956-29-1 |
(-)-Cannabidiol |
(-)-trans-Cannabidiol |
Epidiolex |
CBD |
UNII-19GBJ60SN5 |
(-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol |
delta1(2)-trans-Cannabidiol |
(-)-CBD |
GWP42003-P |
2-(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl-5-pentylbenzene-1,3-diol |
19GBJ60SN5 |
CHEMBL190461 |
CHEBI:69478 |
3556-78-3 |
Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, (-)-(E)- |
2-1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl-5-pentyl-1,3-benzenediol |
C21H30O2 |
1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)- |
2-((1R,6R)-6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol |
(1R,2R)-5-methyl-4-pentyl-2-(prop-1-en-2-yl)-1,2,3,4-tetrahydrobiphenyl-2,6-diol |
Cannabidiol solution |
Cannabidiol USAN |
2-(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl-5-pentyl-1,3-benzenediol |
(-)-Cannabidiol (CBD) |
cannabidiolum |
1,3-Benzenediol, 2-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl-5-pentyl-, (1R-trans)- |
Epidiolex (TN) |
P0T |
Cannabidiol (7CI) |
Cannabidiol (USAN/INN) |
D1(2)-trans-Cannabidiol |
SCHEMBL119679 |
GTPL4150 |
ZYN002 |
2-(6-Isopropenyl-3-methyl-2-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol # |
2-(6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol |
Delta(1(2))-trans-cannabidiol |
DTXSID00871959 |
BTX-1503 |
GWP-42003-P |
GWP42003 |
ZINC4097406 |
BDBM50121429 |
BDBM50318484 |
GWP-42003 |
AKOS032948358 |
DB09061 |
NCGC00386518-01 |
(-)-Cannabidiol 1.0 mg/ml in Methanol |
AC-34022 |
DB-093531 |
Sativex (CBD + THC, fixed-doseoral spray) |
C07578 |
D10915 |
nabiximols (CBD + THC, fixed-doseoral spray) |
Q422917 |
(-)-Cannabidiol (CBD) 100 microg/mL in Methanol |
(-)-Cannabidiol (CBD) 1000 microg/mL in Methanol |
(3R,4R)-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol |
Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, (+-)- |
UNII-K4H93P747O component QHMBSVQNZZTUGM-ZWKOTPCHSA-N |
Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, trans-(-)- (8CI) |
1,3-Benzenediol, 2-(4-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, trans- |
1,3-benzenediol, 2-(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl-5-pentyl- |
2-(3-methyl-6-prop-1-en-2-yl-1-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol |
2-(4-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol trans- |
2-(6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol (Cannabidiol) |
2-(1R,6R)-3-methyl-6-prop-1-en-2-yl-1-cyclohex-2-enyl-5-pentylbenzene-1,3-diol |
2-3-Methyl-6-(methylethenyl)-2-cyclohexen-1-yl-5-pentyl-1,3-benzenediol |
Cannabidiol solution, ~10 mg/mL in ethanol, analytical standard, for drug analysis |
Cannabidiol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
Cannabidiol solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis |
(1R,2R)-5-methyl-4-pentyl-2-(prop-1-en-2-yl)-1,2,3,4-tetrahydro-1,1-biphenyl-2,6-diol" |
(1R,2R)-5-methyl-4-pentyl-2-(prop-1-en-2-yl)-1,2,3,4-tetrahydro1,1-biphenyl-2,6-diol" |
Experimental Data
cannabidiol
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 10 | umol/L | 15.39 | 14.98 | -2.671 | NS | N2 | 33008901 | Inactive | ||||
| Caenorhabditis elegans | 100 | umol/L | 16.08 | 17.11 | 6.396 | S | N2 | 33008901 | Active | ||||
| Drosophila melanogaster | 20 | umol/L | 48.86 | 51.72 | 5.851 | NS | FEMALES | 33008901 | Inactive | ||||
| Drosophila melanogaster | 200 | umol/L | 44.01 | 43.46 | -1.25 | NS | MALES | 33008901 | Inactive |
Experimental Data Visualization
cannabidiol
Statistics Data
cannabidiol
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 6.396 | 1 | 2 | |
| Drosophila melanogaster | 5.851 | 1 | 2 |
Statistics Data Visualization
cannabidiol
